Nevro Share Price Today
(NASDAQ: NVRO)

Name: Nevro Share Price Today (NASDAQ: NVRO) - Nevro Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Nevro share price is $5.79 & ₹503.55 as on 6 Mar 2025, 2.30 'hrs' IST

$5.79

▲

0.06

(1.05%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nevro share price in Dollar and Rupees. Guide to invest in Nevro stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nevro, along with analyst recommendations, forecasts, and comprehensive financials.

Nevro share price movements

Today's Low: $5.74
Today's High: $5.81
$5.79
0.86%
Downside
Day's Volatility :1.2%
Upside
0.34%
52 Weeks Low: $3.17
52 Weeks High: $15.98
$5.79
45.34%
Downside
52 Weeks Volatility :80.19%
Upside
63.77%

Nevro (NVRO) Returns

Period	Nevro Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	40.79%	2.1%	0.0%
6 Months	8.52%	-4.1%	0.0%
1 Year	-60.59%	2.2%	0.0%
3 Years	-91.23%	11.8%	-11.6%

Nevro (NVRO) Key Statistics

in dollars & INR

Previous Close	$5.73
Open	$5.74
Today's High	$5.81
Today's Low	$5.74
Market Capitalization	$216.5M
Today's Volume	$204.5K
52 Week High	$15.98
52 Week Low	$3.165
Revenue TTM	$419.1M
EBITDA	$-73.2M
Earnings Per Share (EPS)	$-1.87
Profit Margin	-16.54%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-24.78%

How to invest in Nevro Stock (NVRO) from India?

It is very easy for Indian residents to invest directly in Nevro from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nevro stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nevro or NVRO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nevro or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nevro shares which would translate to 0.150 fractional shares of Nevro as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nevro, in just a few clicks!

Returns in Nevro (NVRO) for Indian investors in Rupees

The Nevro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Nevro investment value today

Current value as on today

₹44,784

Returns

₹55,216

(-55.22%)

Returns from Nevro Stock

₹60,179 (-60.18%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nevro (NVRO)

100%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nevro Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Nevro

ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
11.52%
Armistice Capital, LLC
9.87%
BlackRock Inc
8.05%
Vanguard Group Inc
5.45%
D. E. Shaw & Co LP
4.76%
BRAIDWELL LP
4.49%

Analyst Recommendation on Nevro

Hold

4%Buy

65%Hold

30%Sell

Based on 23 Wall street analysts offering stock ratings for Nevro(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Nevro Stock (NVRO)

What analysts predicted

Upside of 12.84%

Target:

$6.53

Current:

$5.79

Insights on Nevro Stock (Ticker Symbol: NVRO)

Price Movement
In the last 1 month, NVRO stock has moved up by 14.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 104.16M → 96.91M (in $), with an average decrease of 7.0% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -25.40M → -15.34M (in $), with an average increase of 28.7% per quarter
NVRO vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 54.6% return, outperforming this stock by 113.0%
NVRO vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 135.7% return, outperforming this stock by 227.5%
Price to Sales
ForNVRO every $1 of sales, investors are willing to pay $0.5, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

NVRO Nevro Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$387.3M	↑ 18.56%
Net Income	$-49.2M	↑ 34.23%
Net Profit Margin	-12.7%	↓ 1.48%

	FY19	Y/Y Change
Revenue	$390.3M	↑ 0.77%
Net Income	$-103.7M	↑ 110.72%
Net Profit Margin	-26.57%	↓ 13.87%

	FY20	Y/Y Change
Revenue	$362.0M	↓ 7.23%
Net Income	$-83.1M	↓ 19.89%
Net Profit Margin	-22.94%	↑ 3.63%

	FY21	Y/Y Change
Revenue	$386.9M	↑ 6.87%
Net Income	$-131.4M	↑ 58.14%
Net Profit Margin	-33.95%	↓ 11.01%

	FY22	Y/Y Change
Revenue	$406.4M	↑ 5.03%
Net Income	$3.0M	↓ 102.28%
Net Profit Margin	0.74%	↑ 34.69%

	FY23	Y/Y Change
Revenue	$425.2M	↑ 4.63%
Net Income	$-92.2M	↓ 3172.74%
Net Profit Margin	-21.69%	↓ 22.43%

	Q2 FY23	Q/Q Change
Revenue	$108.8M	↑ 12.96%
Net Income	$-24.7M	↓ 29.42%
Net Profit Margin	-22.72%	↑ 13.64%

	Q3 FY23	Q/Q Change
Revenue	$103.9M	↓ 4.55%
Net Income	$-23.5M	↓ 5.04%
Net Profit Margin	-22.61%	↑ 0.11%

	Q4 FY23	Q/Q Change
Revenue	$116.2M	↑ 11.86%
Net Income	$-9.0M	↓ 61.75%
Net Profit Margin	-7.73%	↑ 14.88%

	Q1 FY24	Q/Q Change
Revenue	$101.9M	↓ 12.29%
Net Income	$-25.4M	↑ 182.92%
Net Profit Margin	-24.94%	↓ 17.21%

	Q2 FY24	Q/Q Change
Revenue	$104.2M	↑ 2.22%
Net Income	$-19.6M	↓ 22.96%
Net Profit Margin	-18.79%	↑ 6.15%

	Q3 FY24	Q/Q Change
Revenue	$96.9M	↓ 6.96%
Net Income	$-15.3M	↓ 21.61%
Net Profit Margin	-15.83%	↑ 2.96%

	FY18	Y/Y Change
Profit	$273.3M	↑ 20.04%

	FY19	Y/Y Change
Profit	$268.4M	↓ 1.82%

	FY20	Y/Y Change
Profit	$249.9M	↓ 6.87%

	FY21	Y/Y Change
Profit	$266.0M	↑ 6.46%

	FY22	Y/Y Change
Profit	$276.4M	↑ 3.88%

	FY23	Y/Y Change
Profit	$290.1M	↑ 4.95%

	Q2 FY23	Q/Q Change
Profit	$74.4M	↑ 15.19%

	Q3 FY23	Q/Q Change
Profit	$69.5M	↓ 6.62%

	Q4 FY23	Q/Q Change
Profit	$78.5M	↑ 12.86%

	Q1 FY24	Q/Q Change
Profit	$67.6M	↓ 13.89%

	Q2 FY24	Q/Q Change
Profit	$67.5M	↓ 0.14%

	Q3 FY24	Q/Q Change
Profit	$64.6M	↓ 4.23%

	FY18	Y/Y Change
Operating Cash Flow	$-5.7M	↓ 60.01%
Investing Cash Flow	$6.4M	↑ 58.1%
Financing Cash Flow	$7.8M	↓ 30.76%

	FY19	Y/Y Change
Operating Cash Flow	$-50.2M	↑ 779.91%
Investing Cash Flow	$32.3M	↑ 402.56%
Financing Cash Flow	$32.1M	↑ 313.89%

	FY20	Y/Y Change
Operating Cash Flow	$1.2M	↓ 102.37%
Investing Cash Flow	$-369.9M	↓ 1244.04%
Financing Cash Flow	$346.9M	↑ 980.94%

	FY21	Y/Y Change
Operating Cash Flow	$-41.9M	↓ 3616.46%
Investing Cash Flow	$201.7M	↓ 154.54%
Financing Cash Flow	$-169.4M	↓ 148.83%

	FY22	Y/Y Change
Operating Cash Flow	$24.7M	↓ 158.92%
Investing Cash Flow	$64.3M	↓ 68.13%
Financing Cash Flow	$-2.5M	↓ 98.55%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-14.5M	↓ 50.53%
Investing Cash Flow	$11.3M	↓ 145.74%
Financing Cash Flow	$4.1M	↓ 281.35%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-6.1M	↓ 58.01%
Investing Cash Flow	$7.3M	↓ 35.4%
Financing Cash Flow	$-1.0M	↓ 124.58%

Nevro Technicals Summary

Sell

Neutral

Buy

Nevro is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Nevro (NVRO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nevro Corp	11.7%	8.52%	-60.59%	-91.23%	-95.21%
Medtronic Plc	2.26%	4.07%	8.74%	-12.76%	0.68%
Edwards Lifesciences Corp.	0.07%	8.12%	-19.19%	-34.12%	12.08%
Boston Scientific Corp.	0.07%	27.33%	53.68%	143.5%	203.93%
Stryker Corporation	-0.63%	8.92%	9.84%	53.87%	125.87%
Abbott Laboratories	7.11%	21.64%	15.28%	15.75%	78.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nevro Corp	157.5	NA	-3.13	-2.41	-0.25	-0.09	NA	7.31
Medtronic Plc	28.75	28.75	1.87	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.5	30.5	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	83.9	83.9	1.85	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.89	50.89	2.85	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nevro Corp	Hold	$216.5M	-95.21%	157.5	-16.54%
Medtronic Plc	Buy	$120.9B	0.68%	28.75	12.83%
Edwards Lifesciences Corp.	Buy	$42.0B	12.08%	30.5	76.75%
Boston Scientific Corp.	Buy	$154.8B	203.93%	83.9	11.07%
Stryker Corporation	Buy	$150.7B	125.87%	50.89	13.25%
Abbott Laboratories	Buy	$238.6B	78.63%	18.34	31.95%

About Nevro

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Organization	Nevro
Employees	1215
CEO	Mr. Kevin R. Thornal
Industry	Health Technology

Management People of Nevro

Name	Title
Mr. Kevin R. Thornal	President, CEO & Director
Mr. Roderick H. MacLeod	Senior VP & CFO
Mr. Kashif Rashid J.D.	Senior VP of Corporate Development & Chief Legal Officer
Mr. Greg Siller	Senior VP & Chief Commercial Officer
Mr. Christofer Christoforou	Senior VP & COO
Ms. Angeline C. McCabe	Vice President of Investor Relations & Corporate Communications
Ms. Shana D. Ross M.B.A.	Senior VP & Chief Human Resources Officer
Dr. David Caraway M.D., Ph.D.	Senior VP & Chief Medical Officer
Mr. Peter A. Socarras	VP, General Counsel & Corporate Secretary

Important FAQs about investing in NVRO Stock from India :

What is Nevro share price today?

Nevro share price today stands at $5.79, Open: $5.74 ; Previous Close: $5.73 ; High: $5.81 ; Low: $5.74 ; 52 Week High: $15.98 ; 52 Week Low: $3.17.

The stock opens at $5.74, after a previous close of $5.73. The stock reached a daily high of $5.81 and a low of $5.74, with a 52-week high of $15.98 and a 52-week low of $3.17.

Can Indians buy Nevro shares?

Yes, Indians can invest in the Nevro (NVRO) from India.

With INDmoney, you can buy Nevro at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Nevro at zero transaction cost.

How can I buy Nevro shares from India?

It is very easy to buy Nevro from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nevro (NVRO) be purchased?

Yes, you can buy fractional shares of Nevro with INDmoney app.

What are the documents required to start investing in Nevro stocks?

To start investing in Nevro, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.